Growth Metrics

Whitehawk Therapeutics (WHWK) Gains from Investment Securities (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Gains from Investment Securities for 8 consecutive years, with $7.5 million as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities changed N/A to $7.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$632000.0 through Dec 2025, up 3.66% year-over-year, with the annual reading at $4.0 million for FY2025, 18.32% down from the prior year.
  • Gains from Investment Securities for Q3 2025 was $7.5 million at Whitehawk Therapeutics, up from $3.4 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $7.5 million in Q3 2025, with the low at -$518000.0 in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $1.2 million, with a median of -$41500.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities surged 1675.71% in 2021, then tumbled 487.1% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $1.0 million in 2021, then plummeted by 97.02% to $31000.0 in 2022, then crashed by 487.1% to -$120000.0 in 2023, then plummeted by 331.67% to -$518000.0 in 2024, then surged by 1550.68% to $7.5 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $7.5 million, $3.4 million, and -$114000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.